OSEBX1 963,65+0,00 %
EQNR371,80+1,03 %
DNB280,60+0,97 %
MOWI205,40+1,18 %
Brent$111,37+0,88 %
Gold$4 579,90−1,07 %
USD/NOK9,2715+0,09 %
EUR/NOK10,8805+0,12 %
SPX7 209,01+0,00 %
NDX27 452,12+0,00 %
LIVE · 09:51 UTC

Xplus Inc

373200 · Specialty Retail · Korea; Republic (S. Korea)

Profile
Ticker373200
RIC373200.KQ
ISINKR7373200005
IssuerXplus Inc
SectorConsumer Discretionary
IndustrySpecialty Retail
Sub-industryCommodity Chemicals
HeadquartersSeoul, Korea; Republic (S. Korea)
Country of issuerSouth Korea
Founded2020-11-25
Employees
Total share float63,332,620
Holders (C/S)9,107
AuditorSam Hwa Accounting Corporation
CEO / managementSang Cheol Yoon
Business Description

Xplus Inc is a Korea-based company principally engaged in manufacture and sale of mobile information technology (IT) devices accessories. The Company is principally engaged in the manufacture and sale of near field communication (NFC) tagging smart accessories such as smart covers, docking stands, wireless chargers as well as intellectual property rights (IP) utilization accessories, custom skins and others.

ESG · Risk Indicators
Controversies score
Governance pillar
Social pillar
Insider trading score
Industry Substrate · Chemicals
Signals to watch
  • Feedstock spread (price - input cost) (leading)
  • Plant utilization rate (coincident)
  • End-market demand (auto, construction, agri) (leading)
  • Inventory destocking/restocking cycles (coincident)
  • Specialty volume growth (trend)
Geopolitical drivers
  • Energy/feedstock cost (Russia gas, Middle East oil) · exposure: high
  • Trade tariffs on chemical exports/imports · exposure: medium-high
  • Environmental regulation (EU REACH, US EPA) · exposure: high
  • Agricultural policy (subsidies, fertilizer demand) · exposure: medium for agri-chem
Industry KPIs
  • EBITDA margin % — 5-15% commodity; 15-25% specialty
  • Capex/sales % — watch trough vs peak
  • Plant utilization % — 82-92% healthy; <80% pressure
  • ROIC — 10%+ specialty; 6-10% commodity through cycle
  • Net debt / EBITDA — below 3.0x healthy; cyclical buffer
Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.